Clinical trials sponsored by CND Life Sciences

Phase breakdown

Conditions studied

Recruiting trials led by CND Life Sciences

• Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease
  NCT07428447 · Phase: Not specified · Ages: 50 Years to 85 Years · Sex: All (male and female) · 4 locations
• Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
  NCT07217054 · Phase: Not specified · Ages: 40 Years to 99 Years · Sex: All (male and female) · 1 location
• Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
  NCT07204652 · Phase: Not specified · Ages: 40 Years to 99 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is CND Life Sciences recruiting for?

CND Life Sciences is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.